1. The Immunization of Protoscolices P29 DNA Vaccine on Experimental Cystic Echinococosis in Balb/c Mice
- Author
-
Mohammad Reza Tabandeh, Mahmoud Rahdar, Zahra Zahra Gharibi, Mehdi Tavalla, and Majid Pirestani
- Subjects
Male ,medicine.medical_specialty ,030231 tropical medicine ,CHO Cells ,030308 mycology & parasitology ,BALB/c ,DNA vaccination ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Medical microbiology ,Cricetulus ,Antigen ,Cricetinae ,medicine ,Vaccines, DNA ,Animals ,0303 health sciences ,Mice, Inbred BALB C ,biology ,Echinococcus granulosus ,Chinese hamster ovary cell ,Vaccination ,biology.organism_classification ,Virology ,Immunization ,Parasitology - Abstract
Cystic Echinococosis is one of the important parasitic diseases that is considered as a problem economics and health in many parts of the world. Many efforts have been performed for controlling the disease in the world. To reach a reliable vaccine against Cystic Echinococosis is one of the important duty of governments. Several antigen of hydatid cyst for vaccine candidate have been evaluated. In this study, P-29 antigen has been used for this purpose. E.g P29 antigen was cloned in Escherichia coli and transfected into the Chinese hamster ovary cell for antigen proliferation and used for vaccination in Balb/c mice. The recombinant antigen E.g-29 was shown using Western blot test. Two dilution of DNA vaccine (pCEgP-29) including 50 µg/100 µl and 100 µg/100 µl were prepared. Twenty four Balb/C male 6–8 week mouse were divided in 4 groups. The groups were included in 2 vaccination groups (pcEg.P29 50 µg/100 µl and 100 µg/100 µl dilution) as immunized groups and 2 groups of plasmid and PBS as control. The mice were injected intramuscularly 3 times with 2 weeks interval. After 3 weeks from last injection, all groups were challenged intraperitonealy with 2000 protoscolices. After 5 months, the mice were euthanized by ketamine/xylasine injection and number, size, and weight of cysts were recorded. Immunization rate was up to 93% in vaccinated group when compared with the control group. The results of this study showed that rEg.P29 could be considered as an effective vaccine for controlling of E. granulosus prevalence in intermediated host.
- Published
- 2021